A randomised controlled trial in preterm infants comparing prophylactic with selective “less invasive surfactant administration” (pro.LISA)

Abstract Background Respiratory distress syndrome is the main cause of mortality and morbidity in preterm infants. “Less invasive surfactant administration” (LISA), which describes intratracheal surfactant administration to spontaneously breathing infants via a small diameter tube, is recommended as...

Descrición completa

Detalles Bibliográficos

Principais autores:	Wolfgang Göpel, Tanja K. Rausch, Barbara Mitschdörfer, Silke Mader, Egbert Herting, Inke R. König, Guido Stichtenoth, on behalf of the pro.LISA study group
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2023-09-01
Series:	Trials
Assuntos:	Surfactant Preterm infant LISA
Acceso en liña:	https://doi.org/10.1186/s13063-023-07603-7
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!